🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Screening of Gastric Cancer Via Breath Volatile Organic Compounds by Hybrid Sensing Approach

Recruitingn/aAges 18 Years - anyAllUniversity of Latvia
NCT04022109 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The study is aimed to determine the potential of volatile marker testing for gastric cancer screening. The study will be addressing the role of confounding factors, including lifestyle factors, diet, smoking as well as addressing the potential role of microbiota in the composition of exhaled volatile markers.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patients with verified gastric cancer (Group 1 \& 2) * Patients undergoing or having undergone upper endoscopy according to clinical indications (Group 3 \& 5) * Average-risk population group aged 40-64 at inclusion without alarm symptoms (Group 4) * Motivation to participate in the study * Physical status allowing volatile marker sampling and other procedures within the protocol * Signed consent Exclusion Criteria: * Known other active cancer * Ventilation problems, airway obstruction * Unwillingness or inability to co-operate
💊

What it tests

  • Breath sampling for VOC detection
  • Surgery material collection for VOC headspace analysis
  • Upper endoscopy
  • Microbiota testing
📍

Where

5 sites
A.C.Camargo Cancer Center
São Paulo, Brazil
Pontificia Universidad Catolica de Chile
Santiago, Chile
Centro Javeriano de Oncología, San Ignacio University Hospital
Bogotá, Colombia
Institute of Clinical and Preventive Medicine, University of Latvia
Riga, Latvia
National Cancer Institute of Ukraine
Kiev, Ukraine
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy